INTRODUCTION
Several foods, including corn, chocolate milk, shrimp and rice salad, have been reported as vehicles [1] . More commonly, however, Listeria monocytogenes causes no evident gastrointestinal lesions or symptoms but rather makes its presence known by severe, life-threatening symptoms involving the central nervous system or the unborn fetus of a pregnant woman.
Pregnant women with listeriosis may experience relatively mild flu-like symptoms themselves. Listeria monocytogenes can spread within their bodies and readily cross the placenta to infect the unborn child. Abscesses develop in the liver, lungs and other fetal organs, and frequently the result is spontaneous abortion or stillbirth. If the baby survives birth, it may be seriously ill with meningitis.
Meningitis is also common in adult victims of listeriosis. Most, but not all, serious cases of listeriosis occur in people who are pregnant, elderly, or have some underlying disease that depresses their immune function. 
INTERNALINS

IRON
Growth in an iron-rich medium enhanced the invasiveness of Listeria monocytogenes for CaCo-2 cells by increasing the expression of internalin genes [11] . Availability of iron also affects expression of the Act A protein [12] .
EFFECTS OF PREGNANCY
The fetus contains traits from the father that are antigenically foreign to the mother, and therefore her immune system should reject the fetus. Although the immunomodulation allows the fetus to survive, it also increases susceptibility to intracellular pathogens, that are normally attacked by the cellular immune system. Listeria monocytogenes, other intracellular pathogens such as Coxiella burnetii, Toxoplasma gondii, and hepatitis E virus may cause severe illness in pregnant women and/or their fetuses [13] . Infants also respond inadequately to listerial infection. Examination of the in vitro immune response to Listeria monocytogenes by one-yearold infants who previously had a severe listerial infection at birth revealed that they produced neither antibodies nor a cell-mediated response to Listeria monocytogenes.
Their immune system had no memory of encountering this pathogen previously. The mothers of these infants did respond immunologically to a challenge with Listeria monocytogenes [11] .
Some experiments with mice indicated that the immune response was impaired in the fetoplacental unit but in other tissues, such as liver and spleen [14] .
Some monocytes and macrophages were observed in the placental region but they were not present at the foci of listerial infection and macrophages were not appropriately activated [15] .
Immunochemical staining confirmed that macrophages were not present in the placenta proper nor were the macrophage inflammatory protein or the monocyte chemoattractant protein detectable in the placenta [16] . All of these deficiencies in immune function permit the growth of listeria monocytogenes in the placenta and fetus.
PATIENTS AND LISTERIA
Immunocompromised individuals are particularly vulnerable to this intracellular pathogen with Listeria infection underlying immonosuppresion [17] .
Other groups of individuals at increased risk include those on drugs which reduce gastric acidity, patients with eithosis, hemochromatosis, and chronic renal failure patients with frequent transfusions. Clinical manifestations of invasive listeriosis are usually severe and include abortion, sepsis, and meningoencephalitis.
Listeriosis can also manifest as a fibrate gastroenteritis syndrome. In addition to humans, Listeriosis monocytogenes affects many vertebrate species, including birds. Pathogenic Listeria enters the host primarily through the intestine. The liver is thought to be the first target organ after intestinal translocation.
ANTIBIOTIC TREATMENT
Bacteriostatic drugs, such as chloramphenicol and tetracycline, are associated with high failure rates in patients with listeriosis and therefore cannot be recommended. Ampicillin or penicillin has generally been recommended as the treatment of choice. Nonetheless, in immunosuppressed patients, relapses have been reported after two weeks of penicillin therapy. The poor response to bacteriostatic drugs and the slow response to penicillin probably result from listeria's ability to survive and grow within cells. The intracellular concentration of ampicillin or penicillin may not be sufficient for complete sterilization.
Immunosuppression reduces the host's ability to clear infected cells, allowing listeria to survive and spread for prolonged periods in a protected intracellular environment. Antibiotic treatment for three to four weeks is therefore recommended in immunosuppressed patients.
Antibiotics that penetrate cells poorly, such as aminoglycosides, may be synergistic in vitro but are unlikely to prove effective in the living host. Although some experts have recommended adding an aminoglycoside to ampicillin, Listeria continues to grow in cells despite extracellular concentrations of 10 to 20μg of gentamicin per milliliter. Aminoglycosides are therefore unlikely to be effective in the treatment of listeriosis and should certainly be avoided in treating kidney-transplant recipients and other patients with renal dysfunction.
Trimethoprim-Sulfamethoxazole, a drug combination that readily enters cells and kills listeria, may be the most effective treatment. This combination has proved effective in patients with listeriosis and hypersensitivity to penicillin. Ampicillin conbined with trimethoprimSulfamethoxazole is associated with a lower failure rate and fewer neurologic sequelae than ampicillin combined with an aminoglycoside.
LISTERIOLYSIN O
As listariae are engulfed, they are enclosed within a vacuole that is surrounded by a membrane. Professional phagocytic cells begin almost immediately to kill the Listeriae within the vacuoles, and survival of Listeria monocytogenes depends on escaping from the vacuole.
Listeriolysin O, a bacterial poreforming toxin, is essential for lysing the vacuolar membrane and allowing listeria monocytogenes to escape into the cytoplasm of the cell. Listeriolysin O is necessary for establishing infection in mice, and its activity is enhanced by the acidic pH in the vacuole[9, [18] [19] [20] [21] [22] [23] .
Mutant
Listeria monocytogenes that do not produce listeriolysin can survive within vacuoles of non-professional phagocytes for a while, but they do not multiply and go on to infect other cells because they cannot escape from the vacuoles.
Analysis of the Listeriolysin O molecule revealed that it contains a series of 27 amino acids at one end that this sequence is very similar to PEST sequences often found on proteins in humans and other animals. In these organisms, the PEST sequence is a starting place for protein-protein interactions and, as such, often indicates proteins slated for degradation. It appears that once Listeriolysin O has done its job of perforating the vacuolar membrane, it is then recognized by enzymes in the cytoplasm of the cells and is destroyed before it can damage the cell membrane [23] .
In addition to its pore-forming function Listeriolysin O participates in other reactions related to pathogenesis of Listeria monocytogenes. Infection of murine spleen and bone marrow dendritic cells by Listeria monocytogenes result in cell death by apoptosis. Mutant bacteria that do not produce Listeriolysin O do not induce apoptosis whereas purified Listeriolysin O can induce this programmed cell death [24] . Listeriolysin O also can act as an inflammatory stimulus by inducing endothelial cell activation [25, 26] and neutrophil activation [27] .
CONCLUSION
The assembly of actin filaments clearly plays a central part in the ability to evade extracellular antibiotic, antibody, and complement action. By usurping the contractile system of the host cell, Listeria can survive and thrive within the host. Actin assembly is essential for the cell-to-cell spread of Listeria, and the oligoprolinecontaining protein. Act A is a primary factor in the virulence of listeriosis. The organism's ability to move through the cytoplasm of host cells and to be transferred from one host cell to another accounts for the increased incidence of infection in patients with defective cell-mediated immunity, as well as accounting for the following clinical characteristics : invasion of the gastrointestinal tract without erosive lesions; a monocytic response in the Cerebro-spinal fluid, with negative Gram's stains; invasion of the cerebral cortex; invasion of the placenta and fetus during maternal bacteremia; and persistent infection despite antibiotic treatment.
